Mohammed Bourdi

3.0k total citations
38 papers, 2.3k citations indexed

About

Mohammed Bourdi is a scholar working on Pharmacology, Hepatology and Oncology. According to data from OpenAlex, Mohammed Bourdi has authored 38 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmacology, 11 papers in Hepatology and 9 papers in Oncology. Recurrent topics in Mohammed Bourdi's work include Drug-Induced Hepatotoxicity and Protection (25 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Mohammed Bourdi is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (25 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Mohammed Bourdi collaborates with scholars based in United States, France and Belgium. Mohammed Bourdi's co-authors include Lance R. Pohl, Timothy P. Reilly, John W. George, Jackie L. Martin, Michael F. Radonovich, John Brady, Philippe Beaune, Yasuhiro Masubuchi, Cynthia Ju and Hamid Amouzadeh and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Mohammed Bourdi

38 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohammed Bourdi United States	27	1.3k	702	480	461	431	38	2.3k
Timothy P. Reilly United States	22	901 0.7×	456 0.6×	402 0.8×	363 0.8×	347 0.8×	35	1.9k
Benjamin L. Woolbright United States	28	839 0.6×	728 1.0×	915 1.9×	857 1.9×	628 1.5×	64	2.8k
Yuchao Xie United States	18	1.5k 1.1×	745 1.1×	450 0.9×	553 1.2×	417 1.0×	23	2.0k
Kuo Du United States	23	1.1k 0.8×	754 1.1×	646 1.3×	794 1.7×	292 0.7×	36	2.3k
Lydiane Pichard‐Garcia France	18	845 0.6×	436 0.6×	348 0.7×	365 0.8×	519 1.2×	27	1.8k
Kazuyoshi Kon Japan	20	526 0.4×	500 0.7×	386 0.8×	778 1.7×	185 0.4×	52	1.6k
Sanda Win United States	20	751 0.6×	645 0.9×	848 1.8×	1.2k 2.7×	266 0.6×	30	2.5k
Lily Dara United States	16	604 0.4×	355 0.5×	589 1.2×	662 1.4×	220 0.5×	32	1.8k
Marcelo G. Roma Argentina	27	580 0.4×	496 0.7×	673 1.4×	808 1.8×	1.2k 2.8×	92	2.7k
S S Thorgeirsson United States	26	1.1k 0.8×	1.2k 1.7×	1.7k 3.5×	579 1.3×	881 2.0×	43	4.1k

Countries citing papers authored by Mohammed Bourdi

Since Specialization

Citations

This map shows the geographic impact of Mohammed Bourdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Bourdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Bourdi more than expected).

Fields of papers citing papers by Mohammed Bourdi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Bourdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Bourdi. The network helps show where Mohammed Bourdi may publish in the future.

Co-authorship network of co-authors of Mohammed Bourdi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Bourdi. A scholar is included among the top collaborators of Mohammed Bourdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Bourdi. Mohammed Bourdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kale, Vijay P., et al.. (2020). Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks. Regulatory Toxicology and Pharmacology. 117. 104750–104750. 7 indexed citations

Bourdi, Mohammed, Udo Rudloff, Samarjit Patnaik, Juan Marugán, & Pramod Terse. (2020). Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells. Regulatory Toxicology and Pharmacology. 116. 104716–104716. 6 indexed citations

Bourdi, Mohammed, Marcelo Amar, Alan T. Remaley, & Pramod Terse. (2018). Intravenous toxicity and toxicokinetics of an HDL mimetic, Fx-5A peptide complex, in cynomolgus monkeys. Regulatory Toxicology and Pharmacology. 100. 59–67. 11 indexed citations

Ulland, Tyler K., Emma E. Hornick, Eric I. Elliott, et al.. (2016). Nlrp12 mutation causes C57BL/6J strain-specific defect in neutrophil recruitment. Nature Communications. 7(1). 13180–13180. 61 indexed citations

Proctor, William R., Mala Chakraborty, Aaron Fullerton, et al.. (2014). Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice. Hepatology. 60(5). 1741–1752. 14 indexed citations

Proctor, William R., Mala Chakraborty, Julia D. Berkson, et al.. (2012). Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice. Hepatology. 57(5). 2026–2036. 44 indexed citations

Lu, Zhongping, Mohammed Bourdi, Jian H. Li, et al.. (2011). SIRT3‐dependent deacetylation exacerbates acetaminophen hepatotoxicity. EMBO Reports. 12(8). 840–846. 68 indexed citations

Bourdi, Mohammed, John Davies, & Lance R. Pohl. (2011). Mispairing C57BL/6 Substrains of Genetically Engineered Mice and Wild-Type Controls Can Lead to Confounding Results as It Did in Studies of JNK2 in Acetaminophen and Concanavalin A Liver Injury. Chemical Research in Toxicology. 24(6). 794–796. 71 indexed citations

Masson, Mary Jane, et al.. (2010). Pathologic role of stressed-induced glucocorticoids in drug-induced liver injury in mice. Biochemical and Biophysical Research Communications. 397(3). 453–458. 21 indexed citations

10.

Perez, Ricardo E., et al.. (2009). Knockdown of ERp57 increases BiP/GRP78 induction and protects against hyperoxia and tunicamycin-induced apoptosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 297(1). L44–L51. 51 indexed citations

11.

Bourdi, Mohammed, Midhun C. Korrapati, Mala Chakraborty, Steven B. Yee, & Lance R. Pohl. (2008). Protective role of c-Jun N-terminal kinase 2 in acetaminophen-induced liver injury. Biochemical and Biophysical Research Communications. 374(1). 6–10. 42 indexed citations

12.

Masubuchi, Yasuhiro, Mohammed Bourdi, Timothy P. Reilly, et al.. (2003). Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochemical and Biophysical Research Communications. 304(1). 207–212. 115 indexed citations

13.

Bourdi, Mohammed, Timothy P. Reilly, Abdel G. Elkahloun, John W. George, & Lance R. Pohl. (2002). Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness. Biochemical and Biophysical Research Communications. 294(2). 225–230. 44 indexed citations

14.

Reilly, Timothy P., Mohammed Bourdi, John Brady, et al.. (2001). Expression Profiling of Acetaminophen Liver Toxicity in Mice Using Microarray Technology. Biochemical and Biophysical Research Communications. 282(1). 321–328. 87 indexed citations

15.

Bourdi, Mohammed, Damon R. Demady, Jackie L. Martin, et al.. (1995). cDNA Cloning and Baculovirus Expression of the Human Liver Endoplasmic Reticulum P58: Characterization as a Protein Disulfide Isomerase Isoform, but Not as a Protease or a Carnitine Acyltransferase. Archives of Biochemistry and Biophysics. 323(2). 397–403. 84 indexed citations

16.

Bourdi, Mohammed, Marina Tinel, Philippe Beaune, & Dominique Pessayre. (1994). Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies.. Molecular Pharmacology. 45(6). 1287–1295. 71 indexed citations

17.

Beaune, Philippe, Mohammed Bourdi, Claire Belloc, et al.. (1993). Immunotoxicology and expression of human cytochrome P450 in microorganisms. Toxicology. 82(1-3). 53–60. 7 indexed citations

18.

Beaune, Philippe & Mohammed Bourdi. (1993). Autoantibodies against Cytochromes P‐450 in Drug‐Induced Autoimmune Hepatitis. Annals of the New York Academy of Sciences. 685(1). 641–645. 13 indexed citations

19.

Bourdi, Mohammed, Jean‐Charles Gautier, Dominique Larrey, et al.. (1992). Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.. Molecular Pharmacology. 42(2). 280–285. 56 indexed citations

20.

Bourdi, Mohammed, Dominique Larrey, J Nataf, et al.. (1990). Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.. Journal of Clinical Investigation. 85(6). 1967–1973. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact